A detailed history of Willis Investment Counsel transactions in Pfizer Inc stock. As of the latest transaction made, Willis Investment Counsel holds 1,220,067 shares of PFE stock, worth $34.1 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares
1,220,067
Previous 1,176,499 3.7%
Holding current value
$34.1 Million
Previous $33.9 Million 0.04%
% of portfolio
2.35%
Previous 2.41%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$25.89 - $29.73 $1.13 Million - $1.3 Million
43,568 Added 3.7%
1,220,067 $33.9 Million
Q4 2023

Jan 11, 2024

BUY
$26.13 - $33.94 $2.77 Million - $3.6 Million
106,048 Added 9.91%
1,176,499 $33.9 Million
Q3 2023

Mar 07, 2024

BUY
$32.09 - $37.51 $1.52 Million - $1.78 Million
47,517 Added 4.65%
1,070,451 $35.5 Million
Q3 2023

Oct 17, 2023

BUY
$32.09 - $37.51 $1.52 Million - $1.78 Million
47,517 Added 4.65%
1,070,451 $35.5 Million
Q2 2023

Mar 07, 2024

BUY
$36.12 - $41.79 $2.01 Million - $2.33 Million
55,732 Added 5.76%
1,022,934 $37.5 Million
Q2 2023

Jul 11, 2023

BUY
$36.12 - $41.79 $2.01 Million - $2.33 Million
55,732 Added 5.76%
1,022,934 $37.5 Million
Q1 2023

Mar 07, 2024

SELL
$39.39 - $51.28 $8.24 Million - $10.7 Million
-209,297 Reduced 17.79%
967,202 $39.5 Million
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $3.35 Million - $4.36 Million
84,963 Added 9.63%
967,202 $39.5 Million
Q4 2022

Jan 18, 2023

BUY
$41.75 - $54.5 $2.56 Million - $3.34 Million
61,361 Added 7.48%
882,239 $0
Q3 2022

Oct 12, 2022

SELL
$43.76 - $53.42 $3.12 Million - $3.81 Million
-71,319 Reduced 7.99%
820,878 $35.9 Million
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $116,836 - $138,531
-2,511 Reduced 0.28%
892,197 $46.8 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $845,094 - $1.05 Million
-18,472 Reduced 2.02%
894,708 $46.3 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $7.26 Million - $10.8 Million
-175,792 Reduced 16.14%
913,180 $53.9 Million
Q3 2021

Nov 17, 2021

BUY
$39.25 - $50.42 $779,308 - $1 Million
19,855 Added 1.86%
1,088,972 $46.8 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1.77 Million - $2 Million
49,188 Added 4.82%
1,069,117 $41.9 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $562,464 - $634,347
-16,795 Reduced 1.62%
1,019,929 $37 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $419,044 - $532,851
12,520 Added 1.22%
1,036,724 $38.2 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $5,746 - $6,742
181 Added 0.02%
1,024,204 $37.6 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $332,946 - $403,913
-11,054 Reduced 1.07%
1,024,023 $33.5 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $32,030 - $45,764
-1,185 Reduced 0.11%
1,035,077 $33.8 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $47,470 - $53,873
1,442 Added 0.14%
1,036,262 $40.6 Million
Q3 2019

Nov 15, 2019

BUY
$32.49 - $42.13 $7.21 Million - $9.35 Million
222,023 Added 27.32%
1,034,820 $37.2 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $15.7 Million - $17.6 Million
424,997 Added 109.59%
812,797 $35.2 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $12.7 Million - $14 Million
-339,138 Reduced 46.65%
387,800 $12.3 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $1.32 Million - $1.51 Million
-34,436 Reduced 4.52%
726,938 $31.7 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $1.87 Million - $2.27 Million
-54,345 Reduced 6.66%
761,374 $33.6 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $57,220 - $61,002
1,735 Added 0.21%
815,719 $29.6 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $2.36 Million - $2.73 Million
-73,804 Reduced 8.31%
813,984 $28.9 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $243,829 - $258,710
7,331 Added 0.83%
887,788 $32.2 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $27.3 Million - $30.1 Million
880,457
880,457 $31.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Willis Investment Counsel Portfolio

Follow Willis Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Willis Investment Counsel with notifications on news.